U.S. Markets open in 23 hrs, 48 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,464.40 | 30.69 | 0.29% |
| NASDAQ | 2,176.05 | 6.87 | 0.32% |
| S&P 500 | 1,110.63 | 4.98 | 0.45% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Date | Time(ET) | Upcoming Events | Set Alert |
|---|---|---|---|
| 03/19/2010 * | 18:00 | Q4 2009 NeurogesX, Inc. Earnings Release |  |
| 12/02/2009 | 17:00 | NeurogesX, Inc. at Piper Jaffray Healthcare Conference | |
| 12/02/2009 | 18:00 | NeurogesX, Inc. at Piper Jaffray Healthcare Conference | |
| Date | Previous Event | Listen | Transcript/Brief |
|---|---|---|---|
| 11/17/2009 | NeurogesX, Inc. at Lazard Capital Healthcare Conference | — | — |
| 11/17/2009 | NeurogesX to Discuss FDA Approval of Qutenza(TM) (capsaicin) 8% Patch for Treatment of Postherpetic Neuralgia (PHN) | — | — |
| 11/06/2009 | Q3 2009 NeurogesX, Inc. Earnings Release | — | — |
| 11/06/2009 | Q3 2009 NeurogesX, Inc. Earnings Conference Call | — | — |
| 11/03/2009 | NeurogesX, Inc. at Oppenheimer & Co. Healthcare Conference | — | — |
| 10/06/2009 | NeurogesX, Inc. at JMP Securities Healthcare Focus Conference | — | — |
| 09/23/2009 | NeurogesX, Inc. at UBS Global Life Sciences Conference | — | Download($) |
| 09/16/2009 | NeurogesX, Inc. at BioCentury `NewsMakers in the Biotech Industry` Clear Route Investment Conference |  |
— |
| 09/10/2009 | NeurogesX, Inc. at Rodman & Renshaw Annual Global Investment Conference | — | — |
| 08/07/2009 | Q2 2009 NeurogesX, Inc. Earnings Release | — | — |
| 08/07/2009 | Q2 2009 NeurogesX, Inc. Earnings Conference Call | — | — |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts